Don't Suggest Xarelto for Most Coronary or Peripheral Artery Disease Patients

December 2018

You'll hear debate about adding Xarelto (rivaroxaban) to aspirin for stable coronary artery disease (CAD) or peripheral artery disease (PAD).

In fact, there's a new Xarelto 2.5 mg dose...to be given twice daily WITH aspirin 81 mg/day to reduce CV events in chronic CAD or PAD patients.

You may hear reps call this the "vascular" dose of Xarelto...versus the 10, 15, and 20 mg doses for venous thromboembolism or atrial fib.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote